126 related articles for article (PubMed ID: 19907337)
1. Predictive modeling of health care costs: do cardiovascular risk markers improve prediction?
Baumeister SE; Dörr M; Radke D; Nauck M; John U; Marschall P; Flea S; Schmidt CO; Alte D; Völzke H
Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):355-62. PubMed ID: 19907337
[TBL] [Abstract][Full Text] [Related]
2. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
Albert MA; Glynn RJ; Buring J; Ridker PM
Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
[TBL] [Abstract][Full Text] [Related]
3. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
4. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
Petersson U; Ostgren CJ; Brudin L; Nilsson PM
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
[TBL] [Abstract][Full Text] [Related]
5. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
[TBL] [Abstract][Full Text] [Related]
6. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
[TBL] [Abstract][Full Text] [Related]
8. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women.
Hu G; Tuomilehto J; Silventoinen K; Barengo N; Jousilahti P
Eur Heart J; 2004 Dec; 25(24):2212-9. PubMed ID: 15589638
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic position, gender, health behaviours and biomarkers of cardiovascular disease and diabetes.
Kavanagh A; Bentley RJ; Turrell G; Shaw J; Dunstan D; Subramanian SV
Soc Sci Med; 2010 Sep; 71(6):1150-60. PubMed ID: 20667641
[TBL] [Abstract][Full Text] [Related]
10. The association between educational level and risk of cardiovascular disease fatality among women with cardiovascular disease.
Lee JR; Paultre F; Mosca L
Womens Health Issues; 2005; 15(2):80-8. PubMed ID: 15767198
[TBL] [Abstract][Full Text] [Related]
11. Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study.
Panagiotakos DB; Pitsavos C; Chrysohoou C; Skoumas I; Stefanadis C;
Vasc Med; 2008; 13(2):113-21. PubMed ID: 18593800
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
13. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
[TBL] [Abstract][Full Text] [Related]
14. Multiple cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.
MacDonald S; Joffres MR; Stachenko S; Horlick L; Fodor G
CMAJ; 1992 Jun; 146(11):2021-9. PubMed ID: 1596851
[TBL] [Abstract][Full Text] [Related]
15. Risk-factor clustering and cardiovascular disease risk in hypertensive patients.
Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Khan ZM; Kaura S; Oster G
Am J Hypertens; 2007 Jun; 20(6):599-607. PubMed ID: 17531915
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors in women with and without rheumatoid arthritis.
Solomon DH; Curhan GC; Rimm EB; Cannuscio CC; Karlson EW
Arthritis Rheum; 2004 Nov; 50(11):3444-9. PubMed ID: 15529391
[TBL] [Abstract][Full Text] [Related]
17. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
18. Ability of physical activity to predict cardiovascular disease beyond commonly evaluated cardiometabolic risk factors.
McGuire KA; Janssen I; Ross R
Am J Cardiol; 2009 Dec; 104(11):1522-6. PubMed ID: 19932786
[TBL] [Abstract][Full Text] [Related]
19. Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry.
Ademi Z; Liew D; Hollingsworth B; Steg PG; Bhatt DL; Reid CM;
Am J Cardiovasc Drugs; 2010; 10(2):85-94. PubMed ID: 20334445
[TBL] [Abstract][Full Text] [Related]
20. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
